Preparing for 2021: Food and Drug Administration and Related Regulatory Challenges

During this program, our speakers will focus on the Food and Drug Administration as well as related regulatory challenges your business might face as we prepare for 2021.

Key Topics

• FDA enforcement and investigations
• Continuing focus on the supply chain, shortages and essential medicines
• User fee reauthorization—developing issues
• FDA inspection challenges amid the continuing pandemic
• Privacy and cybersecurity in clinical trials, connected devices and digital health
• Diagnostics and laboratory-developed tests
• OTC drug developments
• Other recent US trends and emerging risk areas